OH Pharmaceutical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

OH Pharmaceutical is a private, commercial-stage company founded in 2018 and headquartered in San Diego, California, with an operational address in Crown Point, Indiana. Its core product is the UK Injection Kit, an innovative drug delivery system designed to simplify sterile drug reconstitution and administration, reducing error and contamination risks. The company has diversified into consumer wellness with the Kegel Q device and operates a significant services division, acting as a U.S. agent and partner for international firms. OH Pharmaceutical appears to be in an early revenue-generating phase, leveraging a hybrid business model of product sales and service provision.

Drug DeliverySmall Molecules

Technology Platform

Ready-to-Use (RTU) sterile injection system that integrates drug and diluent in a single, aseptically assembled kit designed to reduce preparation steps and contamination risk.

Opportunities

The growing market for outpatient and home-based injectable therapies, especially for biologics and high-risk drugs, creates significant demand for safer, simpler delivery systems like the UK Injection Kit.

Additionally, the company's services division is well-positioned to capitalize on the continuous influx of international life science companies seeking entry into the complex but lucrative U.S.

healthcare market.

Risk Factors

The company faces significant competition from large, established medical device companies in the drug delivery space and must prove the commercial adoption and regulatory standing of its flagship product.

Its hybrid business model and lack of visible leadership or partnerships raise concerns about strategic focus and execution capability with likely limited resources.

Competitive Landscape

For its UK Injection Kit, OH Pharmaceutical competes with major drug delivery device companies like Baxter International, Becton Dickinson, and Schott Pharma, which offer vast portfolios of pre-filled syringes, auto-injectors, and vial systems. In the services arena, it competes with specialized consulting firms and larger CROs/CSOs that offer market entry and business development services to biopharma clients.

More companies in Drug Delivery & Formulation →More companies in United States →